文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

新型内镜混合技术实现三段胆道引流治疗不可切除肝门部恶性胆道狭窄

Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video).
PubMed 文献 · Gastrointest Endosc · 2020-03-10

本研究纳入17例Bismuth IIIa或IV型肝门部恶性胆道狭窄患者,采用部分支架套支架(PSIS)与并排支架(SBS)联合的混合方法行内镜下三段胆道引流。技术成功率为82%(14/17),中位操作时间54分钟,早期胆囊炎发生2例(12%),晚期肝脓肿1例(6%),成功初始三段引流者复发胆道梗阻时间为189天(95%CI 124-254)。结论认为该混合方法有效,操作便利性部分归因于更细的支架输送系统。

要点

  • 混合PSIS与SBS技术可用于Bismuth IIIa/IV型肝门部恶性狭窄的三段胆道引流。
  • 技术成功率82%,中位操作时间54分钟,需注意胆囊炎和肝脓肿风险。
  • 成功初始三段引流者中位复发胆道梗阻时间189天(95%CI 124-254)。

核心结论

  • 混合方法对不可切除肝门部恶性胆道狭窄是有效的内镜引流方法,操作便利性部分归因于更细的支架输送系统。

研究设计与样本

  • 单中心连续病例系列,纳入17例Bismuth IIIa或IV型肝门部恶性狭窄行内镜下混合方法三段胆道引流的患者。
  • 支架输送系统直径为5.4F(n=10)和5.7F(n=7)。

主要发现

  • 技术成功率为82%(14/17),中位操作时间为54分钟。
  • 2例需预扩张才能通过已释放支架网眼置入第三枚自膨式金属支架。
  • 早期不良事件为胆囊炎2例(12%),晚期不良事件为肝脓肿1例(6%)。
  • 成功初始三段引流者复发胆道梗阻时间为189天(95%CI 124-254)。

临床怎么用

  • 对于Bismuth IIIa/IV型肝门部恶性狭窄需三段引流者,可考虑PSIS联合SBS的混合方法。
  • 使用直径<6F的细支架输送系统可能提高操作便利性。
  • 术后需警惕胆囊炎和肝脓肿等不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Three or more stents may be needed in patients with extensive stricturing in Bismuth type IIIa/IV hilar malignant strictures. Partial stent-in-stent (PSIS) deployment has been the primary intervention for hilar malignant biliary stricture (MBS). However, simultaneous side-by-side (SBS) stent placement has become feasible with the development of the <6F diameter stent delivery system. Our aim was to assess the efficacy and safety of a new hybrid method combining PSIS and SBS stent placement for trisegment biliary drainage. METHODS: This study included 17 consecutive patients with Bismuth IIIa or IV malignant strictures who underwent endoscopic drainage using the hybrid method. Diameters of the delivery stents were 5.4F (n = 10) and 5.7F (n = 7). RESULTS: The technical success rate was 82% (14/17), and the median length of procedures was 54 minutes. Two patients required predilatation for deployment of the third self-expandable metallic stent through the mesh of the first deployed stent. Two patients (12%) developed cholecystitis as early adverse events, and 1 patient (6%) developed liver abscess as a late adverse event. The time to recurrent biliary obstruction among those with successful initial trisegmental drainage was 189 days (95% confidence interval, 124-254). CONCLUSIONS: The hybrid method for unresectable hilar MBS is an effective endoscopic drainage method, and the ease of these procedures is partly attributed to the thinner stent delivery system.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Maruki Y, Hijioka S, Wu SYS, et al. Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video). Gastrointest Endosc. 2020. PMID: 32169434. doi:10.1016/j.gie.2020.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。